# Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery

> **NCT06320041** · PHASE4 · RECRUITING · sponsor: **The Fourth Affiliated Hospital of Zhejiang University School of Medicine** · enrollment: 162 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Low dose oxelidine group
- **DRUG:** High dose oxelidine group
- **DRUG:** Hydromorphone group

## Key facts

- **NCT ID:** NCT06320041
- **Lead sponsor:** The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06320041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06320041, "Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06320041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*